News

The investment bank says funding was down 57% last month, to $2.7 billion, and argues the new administration’s FDA ...
Cathie Wood is bullish on biotech companies using gene sequencing, AI, and CRISPR tech to cure previously untreatable ...
China has leaped from fast follower to global pioneer in drug discovery and development. We believe that Chinese companies ...
A dual-track approach has gained momentum for biotech companies as capital markets remain volatile and acquirers become more ...
A new report from Pitchbook suggests we’re in for a period of more sustainable investing, with VC firms continuing to create ...
Regencell's stock soared 17,000% fueled by speculation, despite no revenue or clinical progress. Read why I think the RGC ...
Brooklyn's business park in Sunset Park, Industry City, continues to see tenant demand. Biotech firms Cresilon and Rumi ...
Some promising factors include: FDA approvals for new drugs Capex spending and VC investment in biotech firms AI-assisted breakthroughs in drug development and manufacturing An aging population ...
You can reach Allison on Signal at AllisonDeAngelis.01. Biotech investment firm RA Capital has laid off staff at its internal startup incubator, STAT has learned, highlighting the instability ...
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive ... An announcement from Moleculin Biotech ( (MBRX)) is now available.
CAMBRIDGE, Mass., May 20, 2025 /PRNewswire/ -- Alacrita, a leading life science consulting firm, has expanded its biotech investment and fundraising advisory services with the appointment of Lucas ...